Intestinal dysbiosis fuels liver disease progression via NLRP3 in the Mdr2-/- mouse model of primary sclerosing cholangitis

被引：0

作者：

Liao, Lijun ^{[1
,2
]}

Schneider, Kai Markus ^{[1
]}

Eric, Galvez ^{[3
]}

Frissen, Mick ^{[1
]}

Marschall, Hanns-Ulrich ^{[4
]}

Sun, Huan ^{[1
]}

Hatting, Maximilian ^{[1
]}

Wahlstroem, Annika ^{[4
]}

Haybaeck, Johannes ^{[5
,6
]}

Puchas, Philip ^{[6
]}

Mohs, Antje ^{[1
]}

Jin, Peng ^{[1
]}

Bergheim, Ina ^{[7
]}

Nier, Anika ^{[7
]}

Hennings, Julia ^{[1
]}

Reissing, Johanna ^{[1
]}

Wolfgang, Zimmermann Henning ^{[1
]}

Longerich, Thomas ^{[8
]}

Strowig, Till ^{[3
]}

Liedtke, Christian ^{[1
]}

Cubero, Francisco Javier ^{[1
,9
]}

Trautwein, Christian ^{[1
]}

机构：

[1] Univ Hosp RWTH Aachen, Dept Internal Med 3, Aachen, Germany

[2] Tongji Univ, Shanghai East Hosp, Dept Anesthesiol & Pain Management, Shanghai, Peoples R China

[3] Helmholtz Ctr Infect Res GmbH, Braunschweig, Germany

[4] Wallenberg Inst & Labs, Dept Mol & Clin Med, Gothenburg, Sweden

[5] Univ Magdeburg, Dept Pathol, Magdeburg, Germany

[6] Med Univ Graz, Dept Pathol, Graz, Austria

[7] Univ Vienna, Mol Nutr Sci Div, Dept Nutr Sci, Vienna, Austria

[8] Heidelberg Univ Hosp, Liver Canc Ctr Heidelberg, Heidelberg, Germany

[9] Univ Complutense Madrid, Sch Med, Dept Immunol, Madrid, Spain

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30177-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS-159

引用

页码：E100 / E100

页数：1

共 50 条

[1] Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
Liao, Lijun
Schneider, Kai Markus
Galvez, Eric J. C.
Frissen, Mick
Marschall, Hanns-Ulrich
Su, Huan
Hatting, Maximilian
Wahlstrom, Annika
Haybaeck, Johannes
Puchas, Philip
Mohs, Antje
Peng, Jin
Bergheim, Ina
Nier, Anika
Hennings, Julia
Reissing, Johanna
Zimmermann, Henning W.
Longerich, Thomas
Strowig, Till
Liedtke, Christian
Cubero, Francisco J.
Trautwein, Christian
GUT, 2019, 68 (08) : 1477 - 1492
[2] Intestinal Dysbiosis Augments Liver Disease Progression Via NLRP3 in a Murine Model of Primary Sclerosing Cholangitis
Liao, Lijun
Schneider, Kai M.
Frissen, Mick
Strowig, Till
Marschall, Hanns-Ulrich
Su, Huan
Wahlstrom, Annika
Galvez, Eric J. C.
Mohs, Antje
Kroy, Daniela
Peng, Jin
Jung, Julia
Reissing, Johanna
Wree, Alexander
Zimmermann, Henning Wolfgang
Bieghs, Veerle
Longerich, Thomas
Liedtke, Christian
Javier Cubero, Francisco
Trautwein, Christian
HEPATOLOGY, 2018, 68 : 16A - 17A
[3] The gut-liver axis is essential for disease progression in the Mdr2-/- mouse model of primary sclerosing cholangitis
Liao, L.
Schneider, K. M.
Frissen, M.
Strowig, T.
Marschall, H. -U.
Wahlstroem, A.
Eric, G.
Mohs, A.
Jin, P.
Jung, J.
Reissing, J.
Sun, H.
Elfers, C.
Bieghs, V.
Cubero, F. J.
Trautwein, C.
JOURNAL OF HEPATOLOGY, 2018, 68 : S6 - S6
[4] PROLONGED ADMINISTRATION OF MELATONIN AMELIORATES BILIARY AND LIVER PHENOTYPES IN THE FEMALE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS
Wu, Nan
Ceci, Ludovica
Kennedy, Lindsey
Chen, Lixian
Kyritsi, Konstantina
Barupala, Nipuni
Onori, Paolo
Zhou, Tianhao
Mancinelli, Romina A.
Carpino, Guido
Gaudio, Eugenio
Wu, Chaodong
Franchitto, Antonio
Francis, Heather L.
Alpini, Gianfranco
Glaser, Shannon S.
HEPATOLOGY, 2022, 76 : S1016 - S1016
[5] Mdr2-p-glycoprotein-deficient (Mdr2-/-) mouse - A new model for primary sclerosing cholangitis (PSC)?
Fickert, P
Fuchsbichler, A
Zollner, G
Stumptner, C
Weiglein, A
Zatloukal, K
Denk, H
Trauner, M
HEPATOLOGY, 2001, 34 (04) : 509A - 509A
[6] Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis
Kyritsi, Konstantina
Francis, Heather
Zhou, Tianhao
Ceci, Ludovica
Wu, Nan
Yang, Zhihong
Meng, Fanyin
Chen, Lixian
Baiocchi, Leonardo
Kundu, Debjyoti
Kennedy, Lindsey
Liangpunsakul, Suthat
Wu, Chaodong
Glaser, Shannon
Alpini, Gianfranco
GENE EXPRESSION-THE JOURNAL OF LIVER RESEARCH, 2020, 20 (02): : 89 - 103
[7] FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis
O'Brien, April
Zhou, Tianhao
White, Tori
Medford, Abigail
Chen, Lixian
Kyritsi, Konstantina
Wu, Nan
Childs, Jonathan
Stiles, Danaleigh
Ceci, Ludovica
Chakraborty, Sanjukta
Ekser, Burcin
Baiocchi, Leonardo
Carpino, Guido
Gaudio, Eugenio
Wu, Chaodong
Kennedy, Lindsey
Francis, Heather
Alpini, Gianfranco
Glaser, Shannon
HEPATOLOGY COMMUNICATIONS, 2022, 6 (07) : 1574 - 1588
[8] Blockade of Substance P Receptor attenuates Cellular Senescence and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis
Wan, Ying
Meng, Fanyin
McDaniel, Kelly
Wu, Nan
Venter, Julie
Francis, Heather L.
Zhou, Tianhao
Standeford, Holly
Glaser, Shannon
Alpini, Gianfranco
GASTROENTEROLOGY, 2016, 150 (04) : S1150 - S1151
[9] A New Mdr2-/- Mouse Model of Sclerosing Cholangitis with Rapid Fibrosis Progression, Early-Onset Portal Hypertension, and Liver Cancer
Ikenaga, Naoki
Liu, Susan B.
Sverdlov, Deanna Y.
Yoshida, Shuhei
Nasser, Imad
Ke, Qingen
Kang, Peter M.
Popov, Yury
AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (02): : 325 - 334
[10] Cholestasis induced intestinal dysbiosis augments liver disease in a murine model of primary sclerosing cholangitis
Liao, Lijun
Frissen, Mick
Schneider, Kai M.
Bieghs, Veerle
Marschall, Hanns-Ulrich
Wahlstrom, Annika
Strowig, Till
Mohs, Antje
Reissing, Johanna
Hu, Wei
Peng, Jin
Liedtke, Christian
Cubero, Francisco Javier
Trautwein, Christian
HEPATOLOGY, 2017, 66 : 161A - 162A

← 1 2 3 4 5 →